Back to mobile site
Get it on Google Play

Connect Biopharma reports positive Phase 2 data for COPD drug rademikibart

September 30, 2026 7:00 AM EDT Send to a Friend
Connect Biopharma Holdings Limited (Nasdaq: CNTB) reported positive preliminary topline results from its Phase 2 Seabreeze STAT COPD study evaluating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login